Ulf Dittmer

This study shows HSV infection increases ALS risk and promotes TDP-43 pathology through ICP0-mediated disruption of PML bodies.

This study identifies ISG15 and APOBEC3G as key effectors of IFN-14's enhanced antiviral activity against HIV-1 compared to IFN-2.

This study shows PD-1 is essential for early HBV-specific CD8+ T cell expansion and survival during acute infection but does not suppress effector cytokine function, and its absence impairs proliferation and promotes exhaustion in chronic infection.

This study shows glycyrrhizin inhibits SARS-CoV-2 main protease and neutralizes the virus in vitro, suggesting it as a potential antiviral treatment for COVID-19.